brecka bpc 157 gary The Peptide Craze gary brecka recommended bpc 157

Safety Risks and Side Effects to Be Aware Of Retatrutide's Phase 2 data identified nausea, vomiting, raised resting heart rate, and gallbladder events

In a rat Achilles tendon transection model, BPC-157 improved tendon healing, including functional recovery, biomechanical strength, collagen formation, fibroblast activity, and microscopic tendon organization

The peptide exhibits potent anti-inflammatory properties by modulating cytokine production, reducing pro-inflammatory mediators like TNF- and IL-6 while promoting anti-inflammatory responses

Regulatory Compliance: The FDA highlights the importance of regulatory compliance, which BPC-157 has not fully met according to their standards